東生華 (8432)
東生華 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$325.44M, up 34.1% from a year earlier. EPS over the last four quarters totals NT$4.36.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2012-04-30
- Founded
- 2010-09-01
- Paid-in capital
- NT$383.98M
- Common shares issued
- 38,398,140
- Legal name
- 東生華製藥股份有限公司
- Website
- http://www.tshbiopharm.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$325.44M | +160.8% | +34.1% |
| 2026-08 | NT$124.79M | +16.7% | +30.9% |
Year to date: +19.9% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 1.19 |
| 2026 Q1 | 1.01 |
| 2025 Q4 | 0.62 |
| 2025 Q3 | 1.54 |
| 2025 Q2 | 0.68 |
| 2025 Q1 | 0.79 |
| 2024 Q4 | 0.25 |
| 2024 Q3 | 1.27 |
Last four quarters: NT$4.36
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.61 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 1,127 | 0.4% |
| 1,000–5,000 shares | 1,555 | 7.8% |
| 5,001–10,000 shares | 214 | 4.3% |
| 10,001–15,000 shares | 79 | 2.6% |
| 15,001–20,000 shares | 41 | 1.9% |
| 20,001–30,000 shares | 30 | 1.9% |
| 30,001–40,000 shares | 24 | 2.2% |
| 40,001–50,000 shares | 14 | 1.7% |
| 50,001–100,000 shares | 39 | 7.1% |
| 100,001–200,000 shares | 12 | 4.3% |
| 200,001–400,000 shares | 5 | 4.1% |
| 400,001–600,000 shares | 1 | 1.4% |
| 600,001–800,000 shares | 1 | 1.6% |
| 800,001–1,000,000 shares | 1 | 2.1% |
| 1,000,001+ shares | 1 | 56.5% |
TDCC data for 2026-10-16: 1 holders own more than 1,000 lots (56.5% of shares), and 1,127 hold less than one lot (0.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 9 | 0 | 0 | 9 |
| 2026-10-16 | 4 | 0 | 0 | 4 |
| 2026-10-15 | -9 | 0 | 0 | -9 |
| 2026-10-14 | -13 | 0 | 0 | -13 |
| 2026-10-13 | -7 | 0 | 0 | -7 |
| 2026-10-12 | 15 | 0 | 0 | 15 |
| 2026-10-08 | 0 | 0 | 0 | 0 |
| 2026-10-07 | -9 | 0 | 0 | -9 |
| 2026-10-06 | 0 | 0 | 0 | 0 |
| 2026-10-05 | -1 | 0 | 0 | -1 |
| 2026-10-02 | 1 | 0 | 0 | 1 |
| 2026-10-01 | -1 | 0 | 0 | -1 |
| 2026-09-30 | 14 | 0 | 0 | 14 |
| 2026-09-29 | 12 | 0 | 0 | 12 |
| 2026-09-24 | 0 | 0 | 0 | 0 |
| 2026-09-23 | -1 | 0 | 0 | -1 |
| 2026-09-22 | 0 | 0 | 0 | 0 |
| 2026-09-21 | 1 | 0 | 0 | 1 |
| 2026-09-18 | -6 | 0 | 0 | -6 |
| 2026-09-17 | -1 | 0 | 0 | -1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 8 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$55.40 (2026-10-19); 52-week range NT$48.60–59.30.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.